Kohi Maureen P, Spies James B
Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Department of Radiology, Georgetown University Medical Center, Washington, District of Columbia.
Semin Intervent Radiol. 2018 Mar;35(1):48-55. doi: 10.1055/s-0038-1636521. Epub 2018 Apr 5.
Uterine fibroids (leiomyomas) are the most common benign neoplasm of the female pelvis and have a lifetime prevalence exceeding 80% among African American women and approaching 70% among Caucasian women. Approximately 50% of women with fibroids experience symptoms which may include menorrhagia that may result in anemia, bulk symptoms with bladder and bowel dysfunction and abdominal protrusion, dysmenorrhea, and infertility. Hysterectomy remains the most common treatment option for fibroids and concerns have been raised about the overuse of this procedure. Uterine artery embolization (UAE) is now a well-established uterine preserving and minimally invasive therapy for symptomatic fibroids. Since its introduction, strong evidence for safety and efficacy of UAE has been generated with low rates of complications. This review will discuss UAE for the management of symptomatic uterine fibroids with special focus on emerging technical approaches and novel periprocedural patient care.
子宫肌瘤是女性盆腔最常见的良性肿瘤，在非裔美国女性中的终生患病率超过80%，在白人女性中接近70%。约50%的子宫肌瘤患者会出现症状，可能包括导致贫血的月经过多、膀胱和肠道功能障碍及腹部突出的肿块症状、痛经和不孕。子宫切除术仍然是子宫肌瘤最常见的治疗选择，人们对该手术的过度使用表示担忧。子宫动脉栓塞术（UAE）现在是一种成熟的、用于治疗有症状子宫肌瘤的保留子宫的微创疗法。自引入以来，已产生了关于UAE安全性和有效性的有力证据，并发症发生率较低。本综述将讨论UAE用于治疗有症状子宫肌瘤，特别关注新兴的技术方法和围手术期的新型患者护理。
